heart failure glp-1 New Mechanisms to Prevent with Preserved Ejection Fraction Using Glucagon-like Peptide-1 Receptor Agonism (GLP-1 RA) in Metabolic Syndrome and in Type 2 Diabetes: A Review Gut Hormones in Heart Failure

After eight weeks, leg heaviness was reported to be reduced by 60.4% in the Pycnogenol group compared to a reduction of 12.6% in the placebo group

However, heterogeneity was high for the IV subgroup (I 2 = 52%), and the oral subgroup contained homogeneous studies (I 2 = 0%) (Table 3)

[4] [5] Readers should note that these figures reflect specific trial protocols and may not represent the doses used in ongoing phase 3 studies or any future licensed product

Indeed, an important issue for the potential cognitive and mental health effects of GLP-1RAs, which our analysis cannot fully address, is whether these medications provide symptomatic relief only via their well-established cardiometabolic benefits, or by directly targeting physiopathological mechanisms behind cognitive and mental symptoms

A big step forward for a healthier future

Rare but potentially serious complications may include pancreatitis, gallbladder disease, dehydration, and severe gastrointestinal symptoms